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Abstract The kinetics of the EGF receptor (EGFR) autophosphorylation and of the phosphorylation by EGFR of a fusion protein (Fp(SH2)) 
derived from PLC-7~ with two SH2 domains were studied employing puttied EGFR ormembrane-bound preparations of native and truncated EGFR. 
With varied ATP concentrations both reactions yielded Michaelis-Menten kinetics. KAT  for au ophosphorylation was0.35/2M and for Fp(SH2) 
phosphorylation 1.35/IM. With Fp(SH2) as variable, the velocity curves for substrate phosphorylation by the various EGFR preparations were 
sigmoidal, reached peaks at 0.45 aM Fp(SH2) and were followed by drops to zero velocities at about 1.0/IM Fp(SH2). We conclude that (a) our 
data support the concept tha receptor autophosphorylation is a prerequisite for the interactions between EGFR and the substrate's SH2-domains 
and their eventual phosphorylation by the receptor, and (b) the interactions between EGFR and the physiological substrate seem to involve 
mechanisms which allow the substrate to act as an on-off switch in the subsequent substrate phosphorylation reaction. 
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1. Introduction 
The epidermal growth factor (EGF) receptor (EGFR), like 
many proto-oncogene products, belongs to a large family of 
protein tyrosine kinases (PTKs) which play an important role 
in signal transduction [1,2], a process which involves the con- 
version of an extracellular input signal at the membranal level 
into an intracellular signal which eventually affects gene expres- 
sion at the nuclear level. The activity of the EGFR tyrosine 
kinase (TK) domain, which is similar to that of many other 
oncogene products [3], is controlled by EGF and plays a major 
role in the regulation of cell proliferation. EGFR undergoes 
autophosphorylation on five high affinity tyrosine residues lo- 
calized to the C-terminus of the receptor. The receptor also 
phosphorylates xternal substrates. These two processes are 
markedly enhanced by EGF both in vivo and in vitro. This 
ligand-induced receptor activation requires oligomerization 
(mostly dimerization) of the EGF receptor which brings about 
the process of intermolecular trans-autophosphorylation [4]. 
Although EGFR can phosphorylate various protein substrates 
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in vitro, it is well established that the physiological intracellular 
substrates of the EGFR are proteins which contain the Src 
homology 2 domain (SH2 domain) [5]. Thus, for example, the 
EGF-dependent phosphorylation f PLC-?'I by the EGFR [6] 
involves the high affinity binding of the enzyme to auto- 
phosphorylated receptor molecules through interactions f the 
SH2 domains of PLC-~q with autophosphorylated sites on the 
EGFR including the 5 highly reactive tyrosines of the C-termi- 
nus (Y992, Y1068, Y1086, Y1148 and Y1173) [7]. 
Based on extensive and detailed kinetic studies with EGFR 
isolated from A431 cells with a synthetic opolimer (poly- 
Glu6Ala3Tyr l, GAT), angiotensin II and ATP as substrates, we 
have recently concluded that the TK reaction of the EGFR 
follows a Sequential Rapid Equilibrium Random Bi-Bi mecha- 
nism [8,9]. In view of recent knowledge concerning the involve- 
ment of SH2 domains in the interactions of EGFR with its 
physiological substrates, we decided to study the kinetics of 
phosphorylation of PLC-71 constructs which posses the SH2 
domains by EGFR. 
2. Materials and methods 
2.1. Materials 
Mouse EGF (tissue culture grade) was obtained from Serotec, Ox- 
ford, [7-32p]ATP was purchased from Amersham, UK, ATP was pur- 
chased from B6hringer (Mannheim). Agarose-immobilized wheat germ 
agglutinin was obtained from Biomakor (Rehovoth, Israel). Glutathi- 
one-agarose beads nd all other biochemicals were obtained from 
Sigma (St. Louis, MO, USA) and were of the highest purity available; 
water was deionized by the Barnsted Nanopure system. Monoclonal 
Abl08, a gift from Dr. J. Schlessinger, New York University Medical 
School and Dr. A. Zilberstein, Rhone Poulenc Rorer. CD63cells [10] 
and CD126 cells [11] were a gift from Drs. J. Schlessinger and A. Ulrich 
and the SH2/SH3-containing PLC-?'I-pGEX-3X plasmid were a gener- 
ous gift from Dr. J. Schlessinger. 
2.2. Preparation of EGFR 
EGFR was purified from human epidermoid carcinoma A431 cells 
as described lsewhere [8,12] and stored at -70°C. When subjected to 
immunoblot with anti-EGFR antibodies the purified receptor appeared 
as one band (170 kDa, not shown). Also, when subjected to treatment 
with ATP and EGF and then to immunoblot using antiphosphoty- 
rosine antibodies, a single 170 kDa band was observed (not shown). 
All rights reserved. 
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2.3• Preparation of cell membranes 
NIH3T3/HER 14 cells [12] which express approximately 300,000 na- 
tive EGFR molecules per cell, NIH3T3/CD63 cells (NIH 3T3 cells 
expressing approximately 300,000 molecules per cell of an active EGFR 
mutant lacking 63 amino acids from the C-terminus including the 
2 tyrosine autophosphorylation sites Y1148 and Y1173) and NIH3T3/ 
CD126 cells (which express atruncated EGFR lacking 126 amino acids 
from the C-terminus including the 4 tyrosine autophosphorylation sites 
Y1068, Y1086, Y1148 and Y1173) were grown to confluence in Dul- 
becco modified Eagle's medium - 50 mg/ml penicillin - 10% fetal calf 
serum [10,11,13]. Membranes were prepared as described elsewhere 
[121. 
2.4. Preparation of PLC71-SH 2 domain 
A DNA insert corresponding to the boundaries of the SH2/SH3 
sequences of human PLC-~fi containing the two phosphorylation sites 
Y771 and Y783 and which is ligated into pGEX-3X bacterial expression 
plasmid was a gift of Dr. J. Schlessinger. E. coli were transfected with 
the recombinant plasmid and after confirming that the bacterial trans- 
formants contained the insert, the glutathione S-transferase (GST) fu- 
sion protein was expressed by induction with 1 mM isopropyl fl-o- 
thiogalactopyranoside. TheGST fusion protein (Fp(SH2) was isolated 
from bacterial lysates by affinity chromatography with glutathione- 
agarose beads and elution with 10 mM reduced glutathione [14,15]. 
Protein concentrations were determined by the methods ofScultz et al. 
[16] and Peterson [17]. 
2.5. Assay of EGFR-TK activity 
Assays were performed in nonsterile culture plates with 96 conical 
wells [9,12]. Assay mixtures contained [T-32p]ATP (2-5/aCi), fixed con- 
centrations of Fp(SH2) and increasing concentrations of ATE or vice 
versa, 50 mM Tris-MES, 2 mM MnAc2, 10 mM MgAc2, 0.1 mM 
Na3VO4, 2 mM glutathione, pH 8.0, in total volumes of 20/al. EGFR 
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or membrane preparations were pre-activated immediately prior to use 
by incubation for 30 min at 4°C in presence of 800 nM EGF and 10 
mM MgAc2, 2 mM MnAc2, 100/aM NaaVO4 in 50 mM TM, pH 8.0. 
Reactions were initiated by the simultaneous addition of cold, activated 
EGFR to series of 8 wells with the aid of a multipipetor (5/al/well). In 
some experiments EGFR was preactivated in the presence of 5.0/aM 
ATP and 50 mM Tris-MES, 2 mM MnAc2, 10 mM MgAc2, 0.1 mM 
Na3VO4. pH 8.0 in order to induce autophosphorylation of the receptor 
prior to its addition to reaction mixtures which contained Fp(SH2). 
After incubation at 22°C for time intervals indicated in the text, the 
reactions were stopped by the addition with the aid of the multipipetor 
of 8/11 aliquots of hot (65°C) 4-fold concentrated sample buffer• The 
EGFR and the Fp(SH2) substrate were fractionated by SDS-PAGE, the 
gels were placed on Whatmann 3MM filter paper, dried and autoradi- 
ographed. Films were superimposed on corresponding gels and areas 
corresponding tophosphorylated protein bands were cut out and their 
radioactivity was determined by Cerenkov counting in a Packard 
CD1600 scintillation counter. 
3. Results and discussion 
The phosphorylation of the fusion protein by purified EGFR 
and receptor autophosphorylation were compared with the 
phosphorylation of the fusion protein by native and by trun- 
cated versions of EGFR (CD63 and CD126) present in mem- 
brane preparations and their autophosphorylation. I  these 
studies ATP concentrations were varied while maintaining the 
concentration of the fusion protein constant (0.45/aM ). As can 
be seen in Fig. 1A-D, all reactions followed Michaelis-Menten 
kinetics. The various apparent dissociation constants (i.e. the 
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Fig. 1. Autophosphorylation a d the phosphorylation of Fp(SH2) by purified EGFR and by purified membrane preparations at varying ATP 
concentrations. Autophosphorylation f EGFR at (©) 0/aM Fp(SH2), or (rn) 0.45/aM Fp(SH2), and (o) phosphorylation f 0.45/aM Fp(SH2) by 
(A) purified EGFR, (B) membranes prepared from DHER cells, (C) membranes prepared from CD63 cells and (D) membranes prepared from CD 126 
cells. 
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Fig. 2. Autophosphorylation and phosphorylation f Fp(SH2) at varying Fp(SH2) concentrations. A. (e) EGFR autophosphorylation, (©) phospho- 
rylation of Fp(SH2) at 1.0/IM final [ATP]. Reactions were stopped after 15 s. B. Experimental conditions were as in A, except hat EGFR was 
pre-phosphorylated. ( ) EGFR-P autophosphorylation, (O) phosphorylation f Fp(SH2). C. A comparison between the phosphorylation f Fp(SH2) 
by (A) EGFR and (n) pre-phosphorylated EGFR. D. A characteristic autoradiogram showing EGFR autophosphorylation and the phosphorylation 
of Fp(SH2) at the indicated micromolar concentrations of Fp(SH2). 
apparent K~) for ATP (KATP(EGFR) or KATI~Fp(SH2)) computed 
from these data as described elsewhere [9] are shown in Table 
1. KATP(EGFR ) for the purified EGFR and the membranous na- 
tive EGFR were quite similar. Fp(SH2) slightly increased the 
apparent value of the dissociation constant. Similar KATP(EGFR )
values were observed at higher Fp(SH2) concentrations and at 
longer reaction times (data not shown). The apparent 
KATP(EGFR ) for the CD126 was higher than for CD63 and the 
latter was higher than for the native receptor. The apparent 
KATP(Fp(SH2 ) computed from the plots of the phosphorylation f 
the fusion protein is similar in all four types of EGFR studied 
(Table 1). 
The autophosphorylation of EGFR and the phosphorylation 
of Fp(SH2) by EGFR over a short period of 15 s are shown 
in Fig. 2A. While the autophosphorylation of EGFR decreased 
with increasing Fp(SH2) concentrations, undoubtedly due to 
competition for the receptor's catalytic site, the phosphoryla- 
tion of the fusion protein increased sigmoidally with increasing 
substrate concentrations, but after reaching a peak at about 
0.45 pM Fp(SH2), the reaction rates decreased to practically 
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Fig. 3. Autophosphorylation and the phosphorylation f Fp(SH2) by EGFR and EGFR-E Autophosphorylation of (A) EGFR and (C) EGFR-P 
and the phosphorylation f Fp(SH2) by (B) EGFR or (D) EGFR-P for: ((3) 15 s, (t~) 30 s, (•) 60 s, or (o) 120 s at final [ATP] of 1.0 gM. E. The 
autophosphorylation of EGFR ((3) in the absence and (e) in the presence of 0.45 pM Fp(SH2 and ([]) the phosphorylation f 0.45 pM Fp(SH2) 
by EGFR. F. The autophosphorylation of EGFR-P (©) in the absence and (e) the presence of 0.45 pM Fp(SH2 and (n) the phospborylation f 0.45 
/tM Fp(SH2) by EGFR-E 
zero. Similar results were observed with EGFR which was 
allowed to undergo extensive autophosphorylation (EGFR-P) 
prior to the addition of Fp(SH2) (Fig. 2B). Similar results were 
observed at ATP concentrations smaller and higher than those 
employed in these experiments (1 pM; data not shown). It is 
interesting to note that the phosphorylation of Fp(SH2) by 
EGFR-P reached a peak at a far higher value than the phospho- 
rylation by EGFR which presumably was unphosphorylated 
prior to its transfer to the reaction media (Fig. 2C). These 
results suggest that receptor autophosphorylation s a prerequi- 
site for the interactions between EGFR and substrates contain- 
ing SH2-domains and their eventual phosphorylation by the 
receptor as concluded by others [5]. 
In similar experiments, Fp(SH2) was phosphorylated by 
Table 1 
Values of ATP. EGFR or ATP-Fp(SH2) apparent dissociation con- 
stants (KATp) obtained from kinetic studies. 
Type of reaction 
Type of receptor Receptor auto- Phosphorylation 
phosphorylation of Fp(SH2) 
EGFR 1 (no Fp(SH2)) 0.272 - 
EGFR I 0.353 1.0 
Native EGFR 4 0.413 1.47 
CD63 + 0.523 1.40 
CDl264 0.803 1.34 
~ Purified EGFR; 20 s reaction time. 
2 Values are in gM. 
3 Reactions were performed at 0.45 gM Fp(SH2). 
4Native or truncated EGFR in membrane preparations; 30 s reaction 
time. 
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Fig. 4. Rate of EGFR and EGFR-P autophosphorylation and Fp(SH2) phosphorylation. In (A), (B), (C) and (D) autophosphorylation is i dicated 
by open symbols and the phosphorylation of Fp(SH2) by filled symbols. (A) Phosphorylation by EGFR and (C) Phosphorylation by EGFR-P at 
[FpSH2)] of: (O) and (o) 0.106/aM; (A) and (A) 0.212/aM; (t~) and (1) 0.424/aM. (C) Phosphorylation by EGFR and (D) phosphorytation by EGFR-P 
at [FpSH2)] of: (©) and (e) 0.318/aM; (zx) and (&) 0.612/aM; (o) and (m) 0.816/aM. E. Rates of phosphorylation fFp(SH2) by (©) EGFR and by 
(e) EGFR-P at final [ATP] of 1.0/aM and varying Fp(SH2) concentrations. 
EGFR or by pre-phosphorylated EGFR (EGFR-P) at final 
[ATP] = 1.0/aM over time periods ranging from 0 s to 120 s. 
At all time intervals the autophosphorylation of either EGFR 
or EGFR-P decreased linearly with increasing Fp(SH2) con- 
centrations (Fig. 3A and C, respectively), whereas the phospho- 
rylation of Fp(SH2) increased sigmoidally and reached peaks 
at 0.45/aM Fp(SH2) whether phosphorylated byEGFR or by 
EGFR-P (Fig. 3B and D, respectively). Preliminary experi- 
ments have shown that the autophosphorylation of EGFR time 
curve is hyperbolic (Fig. 3E): there is a rapid initial rate of 
autophosphorylation of EGFR, which represents he phospho- 
rylation of the receptor's highly reactive tyrosine residues that 
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Fig. 5. Autophosphorylation a d phosphorylation f Fp(SH2) by purified EGFR and by purified membrane preparations  varying Fp(SH2) 
concentrations. (e) autophosphorylation of EGFR and (o) phosphorylation f Fp(SH2) by (A) purified EGFR preincubated in the absence of EGF; 
(B) purified EGFR preincubated in the presence of EGF; (C) membranes prepared from DHER cells; (D) membranes prepared from CD63 cells; 
and (E) membranes prepared f om CD126 cells. 
are involved in the EGFR:Fp(SH2) interactions [4,10]; after 
about 60 s, the rate of autophosphorylation te ds to level off 
and possibly involves the phosphorylation f low affinity slowly 
phosphorylated tyrosine residues. Fp(SH2) competes with the 
receptor's autophosphorylation sites for binding to the recep- 
tor's active center and thus causes a decrease in the initial rate 
of autophosphorylation of EGFR. The phosphorylation f the 
fusion protein, Fig. 3E, increases with time to reach far higher 
levels than the receptor autophosphorylation at longer time 
intervals. Fig. 3F shows that despite the relatively long preincu- 
bation of the receptor at ATP concentrations almost 20-fold 
greater the autophosphorylation KAa~ (Table 1), there was 
some further linear increase in the autophosphorylation f 
EGFR-P and that Fp(SH2) caused some inhibition of this auto- 
phosphorylation while the phosphorylation of Fp(SH2) also 
increased linearly with time. The above results suggest that the 
reactions that are relevant for EGFR:Fp(SH2) interactions 
must occur shortly after the initiation of the autophosphoryla- 
tion and Fp(SH2) phosphorylation reactions. 
In view of the above, experiments similar to those shown in 
Fig. 3A-D were repeated at incubation times of 0-120 s and the 
data are shown in Fig. 4A-E. As can be seen in Fig. 4A and 
B, the rate of the autophosphorylation reaction increased hy- 
perbolically with time (i.e. it concaved own) whereas the rate 
of phosphorylation of the fusion protein increased paraboli- 
cally with time (i.e. it concaved up) over the entire range of 
Fp(SH2) concentrations employed. In contrast to these results, 
the phosphorylation of Fp(SH2) by EGFR-P and EGFR-P 
autophosphorylation yielded families of straight line curves 
over the entire range of Fp(SH2) concentration employed 
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(Fig. 4C and D). Initial velocities of the Fp(SH2) phosphorylay- 
tion reaction by EGFR (calculated from 15 s rates seen in Fig. 
4A and B) are compared with initial velocities of the Fp(SH2) 
phosphorylaytion reaction by EGFR-P (calculated from the 
slopes of the curves shown in Fig. 4C and D) in Fig. 4E. Both 
curves are biphasic and far higher ates of Fp(SH2) phosphory- 
laytion by EGFR-P than by EGFR are observed similarly to 
what is seen in Fig. 2C. 
The results of the experiments described above are in support 
of the concept that receptor autophosphorylation is a prerequi- 
site for the interactions between EGFR and substrates contain- 
ing SH2-domains and their eventual phosphorylation by the 
receptor [5]. This is clearly born out by the precursor-product 
kinetic pattern seen in Fig. 4A and B. It is also clear from these 
data that the phosphorylation f the receptor's highly reactive 
tyrosine residues is involved in these interactions as suggested 
by others [5,11]. 
Fig. 5 shows the results of experiments in which the phospho- 
rylation of the fusion protein by EGFR and the auto- 
phosphorylation of EGFR in the absence or the presence of 
EGF are compared with the phosphorylation of the fusion 
protein by native and by truncated EGFR present in different 
membrane preparations and the autophosphorylation of these 
receptors. For the sake of comparison, the ordinates in Fig. 
5A-E are expressed as 'relative activity' which is the extent of 
phosphorylaion f Fp(SH2) or of the autophosphorylation sites 
on the receptor by EGFR kinase observed at each time interval 
relative to the extent of the corresponding autophosphorylation 
reaction observed in the absence of Fp(SH2) in the system. As 
can be seen: (a) in all cases Fp(SH2) causes a slight inhibition 
of the autophosphorylation of the various receptors and (b) the 
phosphorylation of the fusion protein increases igmoidally 
with increasing Fp(SH2) concentrations to a maximum ob- 
served at 0.45/tM Fp(SH2), and then decreases at higher fusion 
protein concentrations, asnoted in the previous experiments. 
The present results have shown that with ATP as variable, 
the phosphorylation byEGFR of a physiological, high affinity 
substrate derived from PLC-yl follows a Bi-Bi sequential rapid 
equilibrium mechanism [8,9]. The KAaV(Fp~SH2) values are in the 
range of 1.0-1.47/tM (Table 1) compared with KAr~EGFR) val- 
ues in the range of 0.35/tM for normal EGFR whether eceptor 
autophosphorylation s monitored in presence or absence of 
Fp(SH2). With the Fp(SH2) substrate as variable, the reaction 
kinetics are quite different han those observed with synthetic 
substrates uch as polyGlurAla3Tyr or Angiotensin II [8]). 
Whereas the interactions between EGFR and the synthetic 
substrates are non-cooperative l ading to Michaelis-Menten 
kinetics [8], in the interactions between EGFR and the physio- 
logical substrate (Figs. 2-5) there is a marked egree of positive 
cooperativity at Fp(SH2) concentrations lower that 0.45/.tM, 
as judged from the sigmoidicity of the velocity curves, and a 
strong effect of substrate inhibition noted at higher Fp(SH2) 
concentrations which are still within the physiological range 
[14]. This is true in the case of purified EGFR as well as in the 
case of membrane-bound EGFR. Thus, the interactions be- 
tween EGFR and a physiological substrate with SH2-contain- 
ing domains eem to involve mechanisms which allow the sub- 
strate to act as an on-off switch in the subsequent substrate 
phosphorylation reaction. 
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